Back to ALL Research Publications
PUBLICATION_
PUBLICATION_
PUBLICATION_
PUBLICATION_
Research Category: ,
Diagnosis and treatment of the invasive extension of bacteria (cellulitis) from chronic wounds utilizing point-of-care fluorescence imaging
Related Publications
Related Material
PUBLICATION_ Use of a bacterial fluorescence imaging system to target wound debridement and accelerate healing: a pilot study
PUBLICATION_ Point-of-care fluorescence imaging predicts the presence of pathogenic bacteria in wounds: a clinical study
PUBLICATION_ Utility of MolecuLight i:X for managing bacterial burden in pediatric burns
PUBLICATION_ The clinical progression and wound healing rate of dehisced perineal tears healing by secondary intention: A prospective observational study
MolecuLight Headquarters
425 University Avenue Suite 700 Toronto, ON M5G 1T6 Canada
US Address MolecuLight Corp. 2403 Sidney Street, Suite 286 Pittsburgh, PA 15203
T. 1-877-818-4360
North American Toll Free:
1-877-818-4360
F.+1 647-362-4730
E: info@moleculight.com
©2025
The MolecuLight® i:X and MolecuLightDX™ Imaging Devices are approved by Health Canada for sale in Canada and has CE marking for sale in the European Union.
The MolecuLight™ i:X and DX Imaging Devices have received FDA clearance.








